3D Conformal Radiation Therapy

3D-CRT: The Basics - Shaping the Beam

• Principle: Conforms radiation dose to the 3D shape of the tumor, improving upon 2D RT.
• Objective: Maximize dose to Planning Target Volume (PTV); minimize dose to Organs at Risk (OARs).
• Beam Shaping Methods:
  • Multileaf Collimators (MLCs):
    • Primary tool for shaping radiation beams in modern 3D-CRT.
    • Consist of multiple (e.g., 80-160) computer-controlled tungsten leaves.
    • Leaves move independently to create a customized field shape.
    • Conform to the target outline from each beam's-eye view (BEV).
  • Custom Blocks (Cerrobend alloy): Older method, less dynamic; may still be used for specific shielding. shaping a radiation beam for 3D-CRT)

⭐ MLCs enable precise beam shaping, significantly reducing radiation exposure to surrounding healthy tissues compared to simple rectangular fields or standard blocks used in 2D RT. This leads to lower toxicity and potential for dose escalation to the tumor.

3D-CRT: Planning Process - Precision Workflow

• Meticulous workflow for precise tumor radiation, minimizing dose to Organs at Risk (OARs).
• Core Stages:
  • Simulation: Patient immobilization (masks/molds), CT imaging in treatment position.
  • Contouring:
    • GTV: Visible tumor.
    • CTV: GTV + microscopic disease.
    • PTV: CTV + margin for setup/motion uncertainties.
    • OARs: Critical structures.
  • Treatment Planning:
    • Beam Arrangement: Multiple static beams shaped (MLCs) to PTV.
    • Dose Calculation: Treatment Planning System (TPS) computes dose.
  • Plan Evaluation: Dose Volume Histograms (DVHs) assess PTV coverage, OAR sparing. Conformity & Homogeneity Indices checked.
  • Quality Assurance (QA): Pre-treatment verification.
  • Treatment Delivery: Via linear accelerator (LINAC).

⭐ The Planning Target Volume (PTV) margin, typically 0.5-1.5 cm around CTV, is vital to ensure CTV coverage despite setup inaccuracies and organ motion.

3D-CRT: Plan Evaluation - Gauging Success

Evaluated using:

• Dose Volume Histogram (DVH):
  • Plot: Dose vs. Volume for PTV & OARs.
  • PTV: $D_{95}$ (dose to 95% PTV), $D_{mean}$.
  • OARs: $D_{max}$, $V_x$ (e.g., Lung $V_{20Gy} < extbf{30-35%}$; Spinal Cord $D_{max} < extbf{45 Gy}$).
• Conformity Index (CI):
  • PTV dose conformity. Ideal = 1.
  • $CI = \frac{V_{RI}}{TV}$ (Ref. Isodose Vol. / Target Vol.).

  ⭐ The Conformity Index (CI) ideally should be 1. Values > 1 indicate irradiation of healthy tissue; values < 1 indicate underdosing of the target.

• Homogeneity Index (HI):
  • PTV dose uniformity.
  • $HI = \frac{(D_{2%} - D_{98%})}{D_{prescription}}$ (ICRU). Lower = better.
• Aim: Max PTV coverage, Min OAR dose.

3D-CRT: Clinical Use - Pros & Cons

Clinical Use:

• Prostate, Breast (post-lumpectomy/WBRT), Lung (non-central/early), Brain (palliative/select primary).
• Palliative care: Bone metastases, symptomatic relief.
• Suits well-defined, convex targets; avoids complex OAR interfaces.

Pros:

• ↑ Conformity & ↓ normal tissue toxicity vs. 2D RT.
• Simpler planning & quality assurance (QA) vs. IMRT.
• Widely accessible & cost-effective.
• Allows moderate dose escalation.

Cons:

• Less conformal than IMRT/VMAT, especially for complex or concave PTVs.
• Higher dose to adjacent OARs compared to IMRT/VMAT.
• Limited sharp dose fall-off near critical structures.
• Suboptimal for most re-irradiation scenarios.

⭐ 3D-CRT significantly reduces dose to normal tissues compared to 2D techniques, enabling safer dose escalation for improved tumor control.

High‑Yield Points - ⚡ Biggest Takeaways

• 3D-CRT delivers radiation dose precisely conforming to the Planning Target Volume (PTV).
• Uses multiple static beams (typically 4-6), shaped by Multileaf Collimators (MLCs).
• Relies on CT-based 3D imaging for accurate target delineation and planning.
• Improves target coverage and normal tissue sparing over 2D RT, reducing toxicity.
• Aims for a homogeneous dose distribution within the PTV.
• Commonly used for prostate, lung, breast, and brain tumors to enhance therapeutic ratio.